Magna: BMO Expects A Poor Quarter After Conducting Channel Checks

Magna International (TSX: MG) is expected to report its third-quarter financial results on November 5th before the market opens. Out of 11 analysts, revenue is expected to be US$7.98 million. Another 11 analysts have a consensus of US$0.60 in earnings per share.

There are 10 analysts covering Magna International with an average 12-month price target of US$106.59. Out of the 10 analysts, 1 has a strong buy rating, 8 have buys and 1 analyst has a hold rating. The street high price target sits at US$126.65 while the lowest comes in at US$82.

In BMO Capital Markets earnings preview they reiterated their Outperform rating but slightly lowered their 12-month price target from US$100 to US$98, saying that they have reduced their third quarter, 2021, and 2022 estimates.

According to BMO’s channel checks, they note that Detroit Three’s production has decreased by 30%, more than their prior 20% estimate. While Western European production decreased by 32% year over year, once again higher than their previous estimate.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

They base their forecasts primarily on their North America data which shows that all but one platform has had a decrease in production units year over year. General Motors production has been getting hit the most, which is down between 17 and 93 percent.

The data for Europe does not look that good either, with every single one of Magna’s European platforms being negative on a year-over-year production basis.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

8 Mining Stocks Our Viewers Asked Us to Review | Sept 14th-18th

Canada Is Finally Fast-Tracking New Mines | John Passalacqua – First Phosphate

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

Silvercorp: Production Results Miss Canaccord Estimates

Last week, Silvercorp Metals Inc. (TSX: SVM) (NYSE: SVM) reported its operational results and announced...

Wednesday, July 21, 2021, 04:39:00 PM

Tesla: Q1 Consensus Estimates

Tesla (NASDAQ: TSLA) will be reporting their first quarter financial results on April 26th after...

Sunday, April 25, 2021, 01:11:00 PM

Green Thumb: Analysts Call For $207 Million In Q2 Revenue

Green Thumb Industries (CSE: GTII) announced that they will be reporting their second quarter financials...

Monday, August 9, 2021, 03:36:00 PM

Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused

On August 3, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Wednesday, September 29, 2021, 11:44:00 AM

Village Farms: Consensus Estimates For Q4 2020

Village Farms (TSX: VFF) (NASDAQ: VFF) will be reporting their fourth quarter and year end...

Monday, March 15, 2021, 11:43:00 AM